Lawrence A. Leiter, M.D., F.R.C.P. (C), F.A.C.P.
Departments of Medicine and Nutritional Sciences

Ph: 416.867.7441
Fax: 416.864.5070


My major clinical research areas include:

  • a) dietary and pharmacologic treatment fo obesity, hyperlipidemia and diabetes,

  • b) appetite regulation including effects of sweeteners,

  • c) adverse effects of dieting and

  • d) metabolic control vs. complications of diabetes.                       

Selected Publications:                                                   


  • DCCT Research Group. The effect of intensive therapy on residual B-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial. Ann Intern Med, 128:518-523. 1998.

  • Leiter, LA, Bhalla, Pankaj. Atorvastatin calcium. A new HMG-CoA reductase inhibitor. Can J Clin Pharmacol; 5(3):138-154. 1998.

  • Chiasson J-L, Gomis R, Hanefeld M, Leiter, L, et al. The STOP-NIDDM Trial. Diabetes Care, 21:1720-1725. 1998.

  • Campbell, NRC, Burgess E, Taylor G, Wilson E, Cleroux J, Fodor JG, Leiter L, Spence JD. Canadian Recommendations for Lifestyle Modification to Prevent and Control Hypertension. Can Med Assoc J. (In Press). 1999.





St. Michael's Health Centre
61 Queen Street East
6th Floor
Toronto, ON
M5C 2T2